Not logged in, please login to view portfolio!



ABOT Share Price | Abbott Laboratories (Pakistan) Limited

ABOT Share Price History

ABOT (Abbott Laboratories (Pakistan) Limited) listed in PSX,ALLSHR,KMIALLSHR,KSE100. ABOT share price / stock price today is 462.01 PKR. Today volume traded in ABOT is 600, price change is -2.38%, high price is 462.01 PKR, and low price is 462.01 PKR.

ABOT Performance
Return (%) Absolute Return
1 Week 1 Month 3 Month 6 Month 1 Year
Return -3.46% 14.93% -4% 24.9% 24.19%

Company Snapshot

loading
ABOT
2024-03-01 16:28:24
Current
462.01
Change
-11.24
Change %
-2.38%
Volume
600.00
Price to Earnings Ratio
106.45
Earning per Share
4.34
Book Value
167.98
Price to Book
2.20
Market Cap
45.23 B
Dividend
0.00
Dividend Yield (%)
0.00 %
Debt to Equity
0.00
Net Profit Margin
0.82 %
Gross Profit Margin
22.91 %
Current Ratio
1.33
Face Value
10.00
Shares
97.9 M
FreeFloat
21.1 M
Free Float %
21.55
Equity to Asset(%)
45.33
Interest
75.75
Beta
0.7648
Upper/Lower Cap
508.74 / 437.76
Times-Revenue Method New
52 Week High
514.00
52 Week Low
330.00
High
462.01
Low
462.01
Previous
473.25
loading

Company Brands

image
image
Company Financials
Company Announcements
Date Announce Title Attachments
2024-02-22 Financial Results for the year ended December 31, 2023 View PDF
2024-02-15 Board Meeting View PDF
2024-01-04 Notice to Shareholders regarding Transfer of Shares Registrar/ Transfer Agent Services (Post Publication) View PDF
2023-12-29 TRANSFER OF SHARES REGISTRAR/ TRANSFER AGENT SERVICES View PDF
2023-12-05 Presentation of Corporate Briefing Session 2023 View PDF
2023-12-01 Notice for Briefing Session View PDF
2023-10-27 Transmission of Quarterly Report for the Period Ended September 30, 2023 View PDF
2023-10-23 Financial Results for the Quarter Ended September 30, 2023 View PDF
2023-10-16 Board Meeting View PDF
2023-08-30 Transmission of Quarterly Report for the Period Ended June 30, 2023 View PDF
2023-08-28 Financial Results for the Quarter ended June 30, 2023 View PDF
2023-08-21 Board Meeting View PDF
2023-06-02 Re-Appointment of Chief Executive View PDF
2023-06-02 Re-Appointment of Chairman View PDF
2023-04-28 Transmission of Quarterly Report for the Period Ended March 31, 2023 View PDF
2023-04-26 Financial Results for the Quarter Ended March 31 2023 View PDF
2023-04-20 Election of Directors View PDF
2023-04-20 Certified copy of Resolutions passed at the 74th Annual General Meeting View PDF
2023-04-19 Board Meeting View PDF
2023-04-12 Notice- Election of Directors View PDF
2023-03-28 Transmission of Annual Report for the Year Ended December 31, 2022 REVOKED View PDF
2023-03-29 Transmission of Annual Report for the Year Ended December 31, 2022 View PDF
2023-03-29 Addendum to the Notice of Annual General Meeting View PDF
2023-03-28 Transmission of Annual Report for the Year Ended December 31, 2022 View PDF
2023-03-28 Notice of Annual General Meeting View PDF
2023-02-22 Financial Results for the Year Ended December 31st, 2022 View PDF
2023-02-15 Board Meeting View PDF
2022-12-23 Presentation of CBS 2022 View PDF
2022-12-07 Notice for Corporate Briefing Session View PDF
2022-10-28 Transmission of Quarterly Report for the Period Ended 2022-09-30 View PDF
2022-10-26 Financial Results for the Quarter Ended 2022-09-30 View PDF
2022-10-14 Board Meeting View PDF
2022-09-23 Credit of Interim Cash Dividend View PDF
2022-08-29 Financial Results for the period ended June 30, 2022 View PDF
2022-08-29 Financial Results for the period ended June 30, 2022 REVOKED View PDF
2022-08-29 Transmission of Quarterly Report for the period ended June 30, 2022 View PDF
2022-08-29 Financial Results for the period ended June 30, 2022 View PDF
2022-08-26 Certified copy of Resolutions passed at the 73rd Annual General Meeting View PDF
2022-08-25 Appointment of Director View PDF
2022-08-22 Board Meeting View PDF
2022-08-01 Appointment of Company Secretary View PDF
2022-05-24 Resignation of Company Secretary View PDF
2022-05-09 Credit of Final Cash Dividend View PDF
2022-05-06 Change of Chairman View PDF
2022-05-06 Transmission of Quarterly Report for the Period Ended March 31, 2022 View PDF
2022-04-28 Financial Results for the Quarter ended March 31, 2022 View PDF
2022-03-29 Transmission of Annual Report for the Year Ended December 31, 2021 View PDF
2022-03-29 Notice of Annual General Meeting View PDF
2022-02-24 Financial Results for the Year Ended December 31, 2021 View PDF
2022-02-17 Board Meeting View PDF
2021-12-10 Notice for Corporate Briefing Session View PDF
2021-10-29 Transmission of Quarterly Report for the Period Ended September 30, 2021 View PDF
2021-10-27 Financial Results for the Quarter Ended September 30, 2021 View PDF
2021-10-21 Board Meeting View PDF
2021-09-23 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2021-09-22 Dispatch of Interim Cash Dividend View PDF
2021-08-27 Transmission of Quarterly Report for the Period Ended June 30, 2021 View PDF
2021-08-27 Financial Results for the Quarter Ended June 30, 2021 View PDF
2021-08-17 Board Meeting View PDF
2021-06-04 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2021-05-04 Credit of Final Cash Dividend REVOKED View
2021-05-04 Credit of Final Cash Dividend View
2021-05-04 Credit of Final Cash Dividend View
2021-04-30 Transmission of Quarterly Report for the Period Ended March 31, 2021 View PDF
2021-04-23 Financial Results for the 1st Quarter Ended March 31, 2021 View PDF
2021-04-22 Certified Copy of Resolution passed at the 72nd Annual General Meeting View PDF
2021-04-16 Board Meeting View
2021-04-06 Board Meeting Other Than Financial Results View PDF
2021-03-31 Transmission of Annual Report for the Year Ended December 31st, 2020 View PDF
2021-03-29 Notice of Annual General Meeting View PDF
2021-03-08 ABOT | Abbott Laboratories (Pakistan) Limited PDF
2021-03-08 Unusual Movement in price or volume of M/s Abbott Laboratories (Pakistan) Limited (ABOT) View
2021-02-26 Financial Results for the Year Ended December 31,2020 View PDF
2021-02-15 Board Meeting PDF

About Company

Abbott Laboratories (Pakistan) Limited is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of branded generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

Address
Plot No. 258 & 324, Opposite Radio Pakistan Transmission Centre, Hyderabad Road, Landhi, Karachi, Pakistan
Website
www.pk.abbott
Key People
Mr. Syed Anis Ahmed CEO
Mr. Ehsan Ali Malik Chairman
Mr. Muhammad Usama Jamil Company Secretary

Page description

ABOT (Abbott Laboratories (Pakistan) Limited) listed in PSX,ALLSHR,KMIALLSHR,KSE100. ABOT Share Price / Stock Price is 462.01 PKR. You can also check; Share Price History, ABOTPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.

ABOT Share Price ABOT Stock Price Abbott Laboratories (Pakistan) Limited psx stock kse100 stock ABOT Stock Price ALLSHR KMIALLSHR KSE100 Share price History ABOT Payouts Annoucements Snapshot ABOT Address ABOT CEO Book Value Price/Book Ratio Dividend Yield Earning Per Share Net Profit Margin Gross Profit Margin Price to Sales Ratio Long Term Debt to Equity Interest Cover (Times) Equity to Assets (%) Current Ratio (Times) Cash Payout Ratio Technical Indicators Moving Averages ABOT Chairperson ABOT Secretary ABOT Website About ABOT

My Watchlist

Not logged in, please login to view watchlist!

Today's Market Performers KSE100

Change
loading

Financial literacy is your key to success and a promise of a secure future in turbulent times. We offer you the right education and resources you need to achieve your financial dreams. Sarmaaya is a trusted source of research and information about Forex, Mutual Funds, and Stocks. Our widgets, tools and calculators aid in identifying potential investment opportunities and valuable insights that can help achieve your short and long-term financial goals.

© 2024 SARMAAYA.PK

Sarmaaya Financials Private Limited is a Pakistan Stock Exchange (PSX) authorized data redistributor. Sarmaaya & CS Solutions (Pvt.) Limited (CS) do not guarantee the timeliness, accurateness, or completeness of any data or information on the website. Sarmaaya & CS makes no warranties, express or implied, as to Sarmaaya & CS or any data or values relating thereto or results to be obtained therefrom, and expressly disclaims all warranties of merchantability and fitness for a particular purpose with respect thereto. To the maximum extent allowed by law, Sarmaaya & CS, its licensors, and their respective employees, contractors, agents, suppliers and vendors shall have no liability or responsibility whatsoever for any injury or damages – whether direct, indirect, consequential, incidental, punitive or otherwise – arising in connection with Sarmaaya & CS or any data or values relating thereto – whether arising from their negligence or otherwise. Nothing in the website shall constitute or be construed as an offering of financial instruments or as investment advice or investment recommendations (i.e., recommendations as to whether or not to “buy”, “sell”, “hold”, or to enter or not to enter into any other transaction involving any specific interest or interests) by Sarmaaya & CS or a recommendation as to an investment or other strategy by Sarmaaya & CS. Data and other information available via the website should not be considered as information sufficient upon which to base an investment decision.